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Abstract 
Background: The salivary glands tumors constitute an important 
area in the field of oral and maxillofacial pathology. Although, such tumors 
are uncommon, thus they are not rare. Pleomorphic adenoma is the most 
common salivary benign tumor and from a histological point of view, it 
contains the epithelial cell, the myo-epithelial cell and mesenchymal 
ingredient. Adenoid cystic carcinoma is an infiltrative malignant salivary 
gland tumor with three different histological patterns: cribriform, tubular or 
solid. RAS is a signal transduction protein for various important cellular 
processes such as cellular proliferation, differentiation, and survival by 
mediating the cell's response to extracellular stimulations. K-ras is a protein 
within the RAS family, and it functions in the same pathway of a Ras –Raf -
Mek-Erk-map kinase pathway which plays a role in mediating cellular 
response to cell growth. K-ras appears to be involved in signal transduction 
and cell cycle regulation. Cyclooxygenase-2, an inducible enzyme in most 
cell types including keratinocytes, fibroblast and Tcell, catalyzes the 
synthesis of prostaglandins. Several processes in cancer may be influenced 
by Cox-2 including cell proliferation, apoptosis, and angiogenesis. 
Therefore, cyclooxygense2 may inhibit apoptosis via different pathways like 
down- regulation of arachidonic, up regulation of proto-oncogene Bcl2 and 
down-regulation of Bax, thus contributing to an increased survival rate. 
Aims of the study: This study was conducted to analyze the 
immunohistochemical expression of K-ras oncogen and Cox-2 enzyme in 
pleomorphic adenoma and adenoid cystic carcinoma of salivary glands and 
to correlate the expression of the studied biomarkers with the clinical 
parameters  and with each other. 
Materials and Methods: In this study, 24paraffin embedded tissue blocks of 
salivary gland tumors were selected retrospectively from the files of the 
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department of Oral pathology at the College of Dentistry, Baghdad 
University; 12 cases were pleomorphic adenoma and the other 12 cases were 
adenoid cystic carcinoma. Immunohistochemistry technique was used to 
assess K-ras oncogen and Cox-2 enzyme expression in these tumors. 
Results: Positive K-ras immunohistochemical expression was found in 11 
(91.6%) and 8 (66.6%) of pleomorphic adenoma and adenojd cystic 
carcinoma studied cases respectively. Regarding Cox-2 expression, the 
results showed positive expression in 7 (58.3%) and1 (91.6 %) of 
pleomorphic adenoma and adenoid cystic carcinoma studied cases 
respectively. Statistically significant correlation was shown regarding K-ras 
expression with the sex of pleomorphic adenoma (P 0.044), while non-
significant correlation was observed with other clinical parameters in 
pleomorphic adenoma and adenoid cystic carcinoma. Concerning Cox-2 
expression, statistically significant correlation revealed with the site of 
pleomorphic adenoma (P 0.046) and the sex of adenoid cystic carcinoma (P 
0.02), while non-significant correlation was found with other clinical 
parameters of both tumors. 
Conclusion: The present study showed a highly expression rate of K-ras in 
pleomorphic adenoma and highly expression rate of Cox-2 in adenoid cystic 
carcinoma. The results also showed that there is no significant correlation 
between the expression rate of both K-ras and Cox-2 among study cases. 
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Introduction 
Salivary gland neoplasms are distinguished because of their 
histological diversity. These neoplasms comprise of benign and malignant 
tumors of epithelial, mesenchymal, and lymphoid origin. From a 
pathological point of view, it is not an easy to make a differentiation of 
benign from malignant tumors; primarily because of the complexity of the 
classification and the rarity of several entities, which may exhibit a broad 
spectrum of morphologic diversity in individual lesions (Speight and Barrett, 
2002).  
Pleomorphic adenoma (PA) is the most common salivary gland tumor 
and it represents 60% to 73% of the parotid gland tumors, 40% to 60% of the 
submandibular and minor salivary glands tumors. (Ito et al,2005). PA is 
comprised of a salivary gland neoplasm with a benign nature. The pathology 
of PA involves ductal epithelial and myoepithelial cell proliferations in a 
mesenchymal stroma exhibiting ostensible histomorphologic diversity 
(Torske, 2006.) 
Adenoid cystic carcinoma (ACC) is a malignant tumor with a 
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deceptively benign histological appearance characterized by indolent and 
locally invasive growth with high propensity for local recurrence and distant 
metastasis. The tumor is composed of basaloid cells with small, angulated, 
and hyperchromatic nuclei and scant cytoplasm arranged prognostically into 
3 significant patterns: cribriform, tubular, and solid (Jaso and Malhotra, 
2011). It is a rare tumor, which accounts for only 1% of all malignant tumors 
of the oral and maxillofacial region (Speight and Barrett, 2002), and 22% of 
all salivary gland malignancies. Also, it is one of the most common 
malignant tumors of the minor salivary and seromucinous glands 
(Kokemueller et al., 2004; Dodd and Slevin, 2006). 
 Numerous studies have attempted to elucidate accurate histological 
prognostic features but have often yielded conflicting results (Jaso and 
Malhotra, 2011). 
GTPase K-ras, known as V-Ki-ras2 Kirsten rat sarcoma viral 
oncogene homolog and K-ras, is a protein that is encoded by the K-
ras gene (Popescu,1985) in humans. The protein product of the normal K-ras 
gene performs an essential function in normal tissue signaling, and the 
mutation of a K-ras gene is an essential step in the development of 
many cancers. Like other members of the Ras family, the K-ras protein is 
a GTPase and is an early player in many signal transduction pathways 
(Kranenburg, 2005). 
Cyclooxygenases (Cox), which are prostaglandin endoperoxide 
synthase, are the rate-limiting enzymes required for the conversion of 
arachidonic acid to prostaglandins (Vane et al, 1998). Cox-1 is constitutively 
expressed in most tissues, and plays a role in regulating normal physiological 
function and inflammation(Pairet and Engelhardt,1996). Cox-2 is expressed 
in inflammatory cells, such as in macrophage, fibroblast and vessel 
endothelial cell after being stimulated by antigens or cytokine (Appleton et 
al., 1995; Majima et al., 1997). Furthermore, Cox-2 has been reported to be 
expressed intensively in various malignancies (Sano et al., 1995;  Hida et 
al.,1998; Zimmermann et al.,1999 ) and it was suggested that Cox-2 
overexpression should correlate with tumor aggressiveness and poor 
prognosis (Tsujii et al., 1997). Thus, the inhibition of Cox-2 activity may 
have a therapeutic value. 
 
Materials and Methods 
In this study, 24 samples of parraffine-embeded blocks of salivary 
gland tumors were included, of which there were 12 cases of PA and 12 
cases of ACC.  
The cases involved in this study were retrospectively obtained from 
the Department of Oral Pathology, College of Dentistry, University of 
Baghdad; and the clinical information obtained from patients' case sheets 
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including age, gender, and lesion area. Therefore, the clinico-pathological 
characteristics of the patients from which the specimens were taken are 
illustrated in table (1) below: 
Table 1:Clinico-pathologic data of studied sample 
 
All the 24 paraffin blocks were cut at 4 µM. From each block, one 
representative section was stained with hematoxylin and eosin for 
reassessment of histopathological diagnosis and two other sections were 
prepared on adhesive slides for immunophistochemical staining with anti K-
ras and  Cox-2 monoclonal antibodies (Abcam). 
Positive control is used for indicating the properness of the staining 
techniques. One positive control was used for each set of test runs. Normal 
skin and colon cancer were used as positive control for K-ras and Cox-2 
respectively. 
The negative control slides were prepared from test tissue and all 
reagents except the primary antibody were applied; thus positive staining 
indicates a lack of specificity of the antibody. 
For immunohistochemistry, the tissue sections on the positively 
charged slides were baked in hot air oven at 65°C for 1 hr. Sections were 
sequentially dewaxed through a series of xylene, graded alcohol and water 
immersion steps. Antigen (Ag) retrieving was done for Cox-2 while this step 
was omitted for K-ras as recommended by the manufacturer. Then, 
endogenous peroxidase activity was blocked, and it was followed by 
blocking the non- specific staining. Primary Abs (100 µl) were applied for 
each section. A dilution of (1-100) for K-ras and (1:50) for Cox-2 were used.  
After an overnight incubation and washing with phosphate buffered solution 
(PBS), secondary Abs were applied, incubated and rinsed with a stream of 
PBS. Primary Abs were visualized with 3,3-diaminobenzidine (DAB) 
chromogen, then counterstained with Mayer's hematoxyline, dehydrated and 
mounted. 
P A Age/ Years Sex Site ACC Age/ Years Sex Site 
1 40 Female parotid 1 42 Male Maxilla 
2 26 Female parotid 2 33 Female Tongue 
3 53 Male Minor s.g. 3 34 Female Floor of mouth 
4 25 Female parotid 4 30 Female Floor of mouth 
5 56 Male parotid 5 31 Female mandible 
6 42 Male parotid 6 44 Male mandible 
7 25 Male parotid 7 45 Female Floor of mouth 
8 50 Female parotid 8 34 Male Soft  palate 
9 50 Female parotid 9 42 Male Hard palate 
10 22 Female Minor s.g. 10 40 Male Parotid gland 
11 28 Male Minor s.g. 11 55 Female Hard palate 
12 30 Male Minor s.g 12 43 Male Floor of mouth 
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The region of staining viewed at 400 magnifications was scored as 
follows. For K-ras, immunohistochemical expression of three punches per 
each case were evaluated and regarded as a whole. The immunoreactivity 
was evaluated on a semi quantitative scale considering the percentage of 
positive cells (score: 0–4 for respectively, <5, 5–20, 20–40, 40–80, >80%) 
(DiFlorio et al ,2007). All cases were divided into four expression groups 
according to their scores which were as follows: score 1=1-20 score 2=20-40 
score 3=40-80 score 4=>80 (DiFlorio et al,2007). For Cox-2, expression was 
evaluated by taking three fields per case. Staining extent was scored as 0 
(0%), 1(1-25%), 2 (26-50%), 3(51-75%) and 4 (76-100%) according to the 
percentage of positively stained cells (Se Min et al., 2010). Therefore, the 
staining intensity was omitted since it may be subjected to personal variation 
during examination. 
 Pearson correlation (χ chi square) test was applied to find the 
relationship of the studied markers with each other and also with the various 
clinical parameters; p value <0.05 was considered significant and the 
statistical analyses were done using SPSS (Statistical Package for Social 
Sciences) V17 (2008). 
 
Results 
Expression of K-ras and Cox-2 
The immunoexpression of K-ras was detected in majority of PA cases 
11(91.6 %), of which 5 cases showed strong immunopositivity, while the 
other 6 cases were moderate. For Cox-2, positive immunoexpression was 
found in 8 cases (66.6%), 4 of them showed score 3, 2 positive cases showed 
score 4 and the remaining 2 positive cases showed score 2 of the expression. 
(Fig.1, 2 and 3) 
In ACC, positive immunoexpression of K-ras was observed in 
7(58.3%), of which 3cases showed strong immunoexpression score, other 3 
cases showed moderate expression score and the remaining one positive case 
showed weak expression score. Concerning Cox-2 immunoexpression, 
present findings showed positive expression in 11(91.6%), of which 5 cases 
showed score 4 of the expression,4 cases showed score 2,and one remaining 
positive case, showed score 3 and the other one showed score 1of the 
expression.(Fig.4,5 and 6). 
 
The correlation of the studied markers with each other and with the 
clinicopathological findings 
Regarding the expression of K-ras, in PA, the results of the present 
study revealed statistically significant correlation of the K-ras expression 
with the sex(p value =0.044),table 2,whereas non-significant correlations 
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were observed with the site and the age of the study sample (P value 0.376 
and 0.135 respectively). 
Concerning ACC, the positive expression of K-ras showed 
statistically non-significant correlations with age, sex, and site (P value 
0.557, 0.519 and 0.315 respectively). 
Regarding the expression of Cox-2, in PA, a statistically significant 
correlation was shown with the site of the study sample (P value =0.046), 
table 3, whereas non-significant correlation observed with the age and sex of 
study sample (P value 0.329 and 0.282) respectively. 
In ACC, the expression of Cox-2 revealed statistically significant 
correlation with the sex (p value =0.02), table 4, whereas non-significant 
correlation were found with age and site of ACC study sample (P value 
0.537 and 0.773) respectively. 
Correlating K-ras and Cox-2 with each other, a statistically non-
significant positive correlation was seen in both PA and ACC (P values 
0.225 and 0.727 respectively) (tables 5 and 6). 
Therefore, the comparison between ACC and PA regarding the scores 
of K-ras and Cox-2 revealed a statistically non-significant correlation (P 
values 0.121 and 0.123 respectively) (Tables 7 and 8). 
Table 2: Correlation of K-ras expression with the sex of pleomorphic adenoma 
Sex  
Scores 
Total 
Relation 
0 1 2 3 4 X2 Likelihood ratio d.f. 
p-
value 
Female No. 1 0 0 1 4 6 
5.467 6.225 2 0.044  
% 100% 0% 0% 16.7% 80% 50% 
Male No. 0 0 0 5 1 6 % 0% 0% 0% 83.3% 20% 50% 
Total No. 1 0 0 6 5 12 % 100% 100% 100% 100% 100% 100% 
 
Table 3: Correlation of Cox-2 expression with the site of pleomorphic adenoma 
Site  
Scores 
Total 
Relation 
0 1 2 3 4 X2 Likelihood ratio d.f. 
p-
value 
Minor 
salivary 
Glands 
No. 3 0 0 0 1 4 
6.375 8.005 3 0.046  
% 75% 0% 0% 0% 50% 33.3% 
Parotid 
Gland 
No. 1 0 2 4 1 8 
% 25% 0% 100% 100% 50% 66.7% 
Total No. 4 0 2 4 2 12 % 100% 100% 100% 100% 100% 100% 
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Table 4: Correlation of Cox-2 expression with the sex of Adenoid cystic carcinoma 
Sex  
Scores 
Total 
Relation 
0 1 2 3 4 X2 Likelihood ratio d.f. 
p-
value 
Female No. 0 0 4 1 1 6 
8.800 11.632 4 0.020  
% 0% 0% 100% 100% 20% 50% 
Male No. 1 1 0 0 4 6 % 100% 100% 0% 0% 80% 50% 
Total No. 1 1 4 1 5 12 % 100% 100% 100% 100% 100% 100% 
 
Table 5: Correlation of  K-ras and Cox-2 with each other in pleomorphic adenoma 
K-
ras  
Cox-2 
Total 
Relation 
0 1 2 3 4 X2 Likelihood ratio d.f. 
p-
value 
0 No. 0 0 0 1 0 1 
6.800 8.179 6 0.225  
% 0% 0% 0% 25% 0% 8.3% 
1 No. 0 0 0 0 0 0 % 0% 0% 0% 0% 0% 0% 
2 No. 0 0 0 0 0 0 % 0% 0% 0% 0% 0% 0% 
3 No. 2 0 0 2 2 6 % 50% 0% 0% 50% 100% 50% 
4 No. 2 0 2 1 0 5 % 50% 0% 100% 25% 0% 41.7% 
Total No. 4 0 2 4 2 12 % 100% 100% 100% 100% 100% 100% 
 
Table 6: Correlation of  K-ras and Cox-2 with each other in adenoid cystic carcinoma 
K-
ras  
Cox-2 
Total 
Relation 
0 1 2 3 4 X2 Likelihood ratio d.f. 
p-
value 
0 No. 0 1 2 1 1 5 
8.080 8.720 12 0.727  
% 0% 100% 50% 100% 20% 41.7% 
1 No. 0 0 0 0 0 0 % 0% 0% 0% 0% 0% 0% 
2 No. 0 0 0 0 1 1 % 0% 0% 0% 0% 20% 8.3% 
3 No. 1 0 1 0 1 3 % 100% 0% 25% 0% 20% 25% 
4 No. 0 0 1 0 2 3 % 0% 0% 25% 0% 40% 25% 
Total No. 1 1 4 1 5 12 % 100% 100% 100% 100% 100% 100% 
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Table 7: Comparison between ACC and PA regarding the scores of K-ras 
Lesion  
Scores 
Total 
Comparison 
0 1 2 3 4 X2 Likelihood ratio d.f. 
p-
value 
ACC No. 5 0 1 3 3 12 
5.167 5.822 3 0.121  
% 83.3% 0% 100% 33.3% 37.5% 50% 
PA No. 1 0 0 6 5 12 % 16.7% 0% 0% 66.7% 62.5% 50% 
Total No. 6 0 1 9 8 24 % 100% 0% 100% 100% 100% 100% 
 
Table 8: Comparison between ACC and PA regarding the scores of   Cox 2 
Lesion  
Scores 
Total 
Comparison 
0 1 2 3 4 X2 Likelihood ratio d.f. 
p-
value 
ACC No. 1 1 4 1 5 12 
6.552 7.249 4 0.123  
% 20% 100% 66.7% 20% 71.4% 50% 
PA No. 4 0 2 4 2 12 % 80% 0% 33.3% 80% 28.6% 50% 
Total No. 5 1 6 5 7 24 % 100% 100% 100% 100% 100% 100% 
 
 
 
 
 
 
Figure1: Positive expression of                                  Figure2: Positive expression of 
K-ras in PA(X40)                                                           K-ras in PA(X20) 
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Figure 3: Positive expression of                           Figure 4: Positive expression of 
Cox-2 in PA(X40)                                                         K-ras in ACC(X20) 
 
             
Figure 5: Positive expression of                      Figure 6: Positive expression of 
K-ras in ACC (X40)                                          Cox-2 in ACC (X40) 
 
Discussion  
The results of the current study overemphasized the important role played 
by K-ras in PA. About 92% of PA cases exhibited immunoreactivity for K-
ras. These findings are consistent with other studies in which the KRAS 
protein was reported to be an early player in many signal 
transduction pathways (Kranenburg, 2005). Other studies pointed to 
detection of ras genes in several malignant neoplasms of diverse origin (Yoo 
and Robinson, 2000).  K-ras mutations are more likely to occur in tumors 
from glandular epithelial tissues. K-ras mutation occurs mainly in mucin-
producing adenocarcinomas (Bos, 1998).  However, our data do not agree 
with studies reported by Yoo and Robinson (2000) who found only 8% 
mutations of the K-ras gene in salivary gland tumors. The expression of 
COX-2 in PA in the present study was about 67%. Our data did not agree 
with other studies as the study of Sakurai (2001) who demonstrated an 
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increased expression of COX-2 in 90% of cases with salivary gland tumors.  
     The expression of K-ras in ACC was shown in about 58% of cases, while 
the expression of COX-2 was shown in about 92% of ACC cases. These 
findings suggested that the role of COX-2 in ACC is more pronounced 
compared with K-ras, while this relation was inversed in PA. It is worth to 
mention that COX-2 is down-regulated in estrogen deficient animals when 
they have been treated with high concentrations of estrogen (Radeva, 1977).  
    Regarding correlation of studied biomarkers with each other, the data of 
the present study pointed to independent pathways between K-ras and Cox-2 
in both PA and ACC.This finding disagree with other studies that 
investigated the relationship between the expression of K-ras and Cox-2 in 
other types of tumors. Li et al (2006) conducted a study in the light of the 
fact that K-ras plays an important role in the induction of COX-2 expression 
in tumor cells. They reported a significant correlation between the expression 
rate of COX-2 and K-ras in gastric cancer.  
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